Article archive / October 1, 2015
Originally published: . Volume 6, No. 10. Source pages: 5.
A new study published in September contradicts a 2001 study that said the widely prescribed antidepressant, Paxil, was safe and effective for treating depression in adolescents. The reversal is based on a reanalysis of research from 2001. According to CBS News, the reanalysis of the drug trail is the first by a group of researchers who work to correct erroneous studies.
The original study was funded by SmithKline Beecham, now called GlaxoSmithKline, and was called Study 329. Study 329 has received criticism over the years said the CBS report. The New York State Attorney General sued the drug company for misrepresenting data on the medication and they agreed to pay $3 billion in fines.
This article is part of a historical newspaper archive. Read the original issue for its original layout, photographs and graphics.